Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

THI Edit page article on HIV-Self Testing (HIVST) in Mizoram entitled, "From stigma to solutions" (March 8) is interesting ...

LEN is a first-in-class, long-acting HIV-1 capsid inhibitor that disrupts multiple stages of the viral replication cycle. By ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

And even universities, a bastion of progressive ideology, are suddenly backing away a bit, or treading carefully. Almost all of this shift happened because of the work of one man who is arguably the ...

Queer HIV activist opens up about Trump and Musk's USAID cuts Ruele Okeyo posts videos of himself on TikTok taking his HIV medication. He says it is to reduce the stigma around it. But after USAID ...

Dr Mark Shrime is a Lecturer in Global Health and Social Medicine at Harvard Medical School. Clinically, he specialises in treating head and neck tumors, working with Mercy Ships. His academic ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The new Mexican law aims to ...